Abstract
Objective: Accumulating evidence indicates that prostate cancer is associated with high levels of serum IGF-I. This study was conducted to determine whether a low-fat diet and exercise (DE) intervention may modulate the IGF axis and reduce prostate cancer cell growth in vitro. Methods: Fasting serum was obtained from 14 men (age 60 ± 3 years) participating in an 11-day DE program and from eight similarly aged men who had followed the DE program for 14.2 ± 1.7 years (long-term). Insulin, IGF-I, IGFBP-1, and IGFBP-3 were measured by ELISA, and serum was used to stimulate LNCaP cell growth in vitro. Results: Serum IGF-I levels decreased by 20% while IGFBP-1 increased by 53% after 11-day DE. In the long-term group, IGF-I was 55% lower, while IGFBP-1 was 150% higher relative to baseline. Serum insulin decreased by 25% after 11-day DE and was 68% lower in the long-term group, relative to baseline. No changes in serum IGFBP-3 were observed. Serum-stimulated LNCaP cell growth was reduced by 30% in post-11-day serum and by 44% in long-term serum relative to baseline. LNCaP cells incubated with post-DE serum showed increased apoptosis/necrosis, compared to baseline. Conclusions: A low-fat diet and exercise intervention induces in-vivo changes in the circulating IGF axis and is associated with reduced growth and enhanced apoptosis/necrosis of LNCaP tumor cells in vitro.
Similar content being viewed by others
References
Giovannucci E, Rimm EB, Colditz GA, et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571–1579.
Griffiths K, Boyle P (1995) Diet and prostate disease. Eur Urol Today 5: 9.
Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43–68.
Whittemore AS, Kolonel LN, Wu AH, et al. (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87: 652–661.
Fradet Y, Meyer F, Bairati I, Shadmani R, Moore L (1999) Dietary fat and prostate cancer progression and survival. Eur Urol 35: 388–391.
Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD (1995) Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87: 1456–1462.
Kondo Y, Homma Y, Aso Y, Kakizoe T (1994) Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 54: 6129–6132.
Tymchuk CN, Barnard RJ, Heber D, Aronson WJ (2001) Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 166: 1185–1189.
LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol Rev 16: 143–163.
Chan JM, Stampfer MJ, Giovannucci EL (1998) What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 8: 263–273.
Ritchie CK, Andrews LR, Thomas KG, Tindall DJ, Fitzpatrick LA (1997) The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease. Endocrinology 138: 1145–1150.
Iwamura M, Sluss PM, Casamento JB, Cockett AT (1993) Insulinlike growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243–252.
Wolk A, Mantzoros CS, Andersson SO, et al. (1998) Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90: 911–915.
Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO (1997) Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76: 1115–1118.
Stattin P, Bylund A, Rinaldi S, et al. (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92: 1910–1917. 934 T.H. Ngo et al.
Chan JM, Stampfer MJ, Giovannucci E, et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563–566.
Cohen P, Peehl DM, Rosenfeld RG (1994) The IGF axis in the prostate. Horm Metab Res 26: 81–84.
Collett-Solberg PF, Cohen P (1996) The role of the insulinlike growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin N Am 25: 591–614.
Ferry RJ Jr, Katz LE, Grimberg A, Cohen P, Weinzimer SA (1999) Cellular actions of insulin-like growth factor binding proteins. Horm Metab Res 31: 192–202.
Katz LEL, Rosenfeld RG, Cohen P (1995) Clinical significance of insulin-like growth factor binding proteins (IGFBPs). Endocrinologist 5: 36–43.
Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD (1992) Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 74: 1355–1360.
Tymchuk CN, Tessler SB, Aronson WJ, Barnard RJ (1998) Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer 31: 127–131.
Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472–1489.
Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR (1994) Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42: 145–151.
Smith WJ, Underwood LE, Clemmons DR (1995) Effects of caloric or protein restriction on insulin-like growth factor-I (IGFI) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80: 443–449.
Rosenthal MB, Barnard RJ, Rose DP, Inkeles S, Hall J, Pritikin N (1985) Effects of a high-complex-carbohydrate, low-fat, lowcholesterol diet on levels of serum lipids and estradiol. Am J Med 78: 23–27.
Tymchuk CN, Barnard RJ, Ngo TH, Aronson WJ (2002) The role of testosterone, estradiol, and insulin in diet and exercise-induced reductions in serum-stimulated prostate cancer cell growth in vitro. Nutr Cancer (In Press).
Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB (1992) Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 69: 440–444.
Phillips LS, Harp JB, Goldstein S, Klein J, Pao CI (1990) Regulation and action of insulin-like growth factors at the cellular level. Proc Nutr Soc 49: 451–458.
Harp J, Goldstein S, Sertich G, Phillips L (1989) Regulation of hepatic IGF-1 production by amino acids. Clin Res 37 (abstract).
Phillips LS, Goldstein S, Pao CI (1991) Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 40: 1525–1530.
Conover CA, Butler PC, Wang M, Rizza RA, Lee PD (1990) Lack of growth hormone effect on insulin-associated suppression of insulin-like growth factor binding protein 1 in humans. Diabetes 39: 1251–1256.
Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66: 266–272.
Rosen CJ (2000) Growth hormone and aging. Endocrine 12: 197–201.
Singh MA, Ding W, Manfredi TJ, et al. (1999) Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol 277: E135–E143.
Signorello LB, Brismar K, Bergstrom R, et al. (1999) Insulin-like growth factor-binding protein-1 and prostate cancer. J Natl Cancer Inst 91: 1965–1967.
Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10: 297–305.
Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM (1999) The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59: 2203–2209.
Cohen P (1998) Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J Natl Cancer Inst 90: 876–879.
Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll PR (2001) Dietary trial in prostate cancer: early experience and implications for clinical trial design. Urology 57: 200–201.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ngo, T.H., Barnard, R.J., Tymchuk, C.N. et al. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13, 929–935 (2002). https://doi.org/10.1023/A:1021911517010
Issue Date:
DOI: https://doi.org/10.1023/A:1021911517010